Exclusive: ACR Convergence 2024| Focus Rheums

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Pharmacy Benefit Managers Under Scrutiny

Elizabeth Hofheinz, MPH, MEd  |  Issue: June 2024  |  

Elizabeth Hofheinz, MPH, MEd, is a freelance medical editor and writer based in the greater New Orleans area.

References

  1. Fein AJ. The top pharmacy benefit managers of 2021: The big get even bigger. Drug Channels. 2022 Apr 5. https://www.drugchannels.net/2022/04/the-top—managers-of.html.
  2. Morse S. PBMs are driving up drug prices through fees, PhRMA report claims. Healthcare Finance. 2023 Sep 18. https://www.healthcarefinancenews.com/news/pbms-are-driving-drug-prices-through-fees-phrma-report-claims.

Related Articles

    Rheumatologists Air Frustrations with Pharmacy Benefit Managers at Annual Meeting

    SAN DIEGO—Pharmacy benefit managers (PBMs) and their impact on drug prices and access to high-cost medications by the patients rheumatologists treat was a major theme at the 2017 ACR/ARHP Annual Meeting Nov. 3–8. In one session, industry experts tried to clarify the role for prior authorizations and drug formulary policies and explored ways to constructively…

    Arkansas PBM Bill: A Step in the Right Direction

    During a three-day special legislative session in March, Arkansas Governor Asa Hutchinson (R) signed into law the first bill in the U.S. intended to address a lack of transparency among pharmacy benefit managers (PBMs) and their role in the high cost of prescription drugs.1 The bill, H.B. 1010: Arkansas Pharmacy Benefits Manager Licensure Act, will…